Advancing toxicity prediction in CAR-T cell therapy
Despite recent advances in the field, Chimeric Antigen Receptor T (CAR-T) cell toxicities remain a significant burden throughout both the early and late post-infusion periods, affecting patient outcomes and complicating clinical management. Several ris…